Search

Reading Time: 4 minutesChimeric antigen receptor T-cell (CAR-T) therapies have demonstrated significant promise in treating hematological and other malignancies.[1] But there are several areas that require a deeper understanding for the development, approval, and sale of CAR-T therapies; these include the long-term therapeutic benefits, risk of serious adverse events, and healthcare resource utilization (HCRU). Due to the risks […]

Article

Reading Time: < 1 minuteChimeric antigen receptor (CAR) T-cell treatment is a promising immunotherapy for multiple hematological cancers, especially for patients who have exhausted other treatment options. While CAR-T therapy represents hope for these patients, it can come with serious and life-threatening side effects. Cytokine Release Syndrome (CRS)—sometimes called a cytokine storm—is one of the most common CAR-T cell […]

Article

Reading Time: 4 minutesThe world of clinical data management is rapidly changing, and so too are the skills and processes associated with today’s data managers. New data sources bring in higher volumes of data at faster speeds, giving teams more insights around patients than ever before. But data managers continue to face challenges with regards to data collection […]

Article

Reading Time: 2 minutes This blog was authored by Alicia Staley. Alicia is the VP of Patient Engagement at Medidata and leads Medidata’s Patient Insights Board. For the past 10 years, no phrase in the clinical trial industry has been overused more than “patient centricity.” Until today. Go to any conference and you’ll see that the new buzzword […]

Article

Reading Time: 2 minutes Decentralized clinical trials (DCTs) have revolutionized clinical research. As trials become more complex, precise, and personalized, embracing this new landscape of patient-focused solutions is critical to ensure success and scalability. What has been the impact of DCT platforms, and what should companies consider when evaluating the model for decentralized trials? Medidata Patient Cloud CEO, Anthony […]

Article

Reading Time: 3 minutesDiversity in clinical trials has been a long-standing issue across clinical research. Studies have historically failed to represent the patient population, with the majority of patients enrolled in trials being White, younger men. This has caused not only gaps in the industry’s understanding of how treatments in certain disease areas broadly affect diverse populations, but […]

Article

Reading Time: 3 minutesThis blog was authored by Marc Kaufman, Senior Product Director, Product Management at Medidata. Clinical trials are becoming more complex, with an average of 3.6 million data points collected in Phase III studies.1 Despite this and rising development costs, trial approvals and success rates have not improved. Unsurprisingly, adaptive clinical trial designs are being […]

Article

Reading Time: 4 minutesMedidata’s Rave (electronic data capture) system is designed to meet the flexibility challenges of clinical trials. It requires no downtime when executing mid-study changes that are preplanned (adaptive trial design) or unplanned (protocol amendments). Medidata and our customers perform an average of over 30,000 mid-study changes per year (2019-2022) and a total of 300,000+ since 2005, including […]

Article

Reading Time: 3 minutesThis blog was authored by Nicole Montgomery, Director, Product Marketing at Medidata. You’re either riding the innovation wave with a seamless, completely digital, end-of-study process or you’re wasting time and money burning end-of-study PDFs onto physical media. This time-consuming process involves labeling, packaging, relabeling, shipping to the site, and waiting for the site to receive, […]

Article

Reading Time: 3 minutesAt an insightful SCDM (Society for Clinical Data Management) EMEA conference last week, over 200 attendees came together from pharma/biotechs, CROs, regulators, and technology providers on the AstraZeneca campus in Gothenburg, Sweden. The Medidata team had the privilege of joining the pre-conference Leadership Forum with in-depth discussions on transforming clinical data management organizations into clinical […]

Article

Reading Time: 3 minutesKC Ahlberg is a Director of Partners and Alliance Management at HealthVerity, one of Medidata Link’s clinical trial tokenization partners which supports patient-level linkage between clinical trial data (CTD) and real-world data (RWD). We spoke with KC to discuss some of the key trends related to the use of real-world data in clinical trials, and […]

Article

Reading Time: 4 minutes “Let the Beauty of What You Love Be What You Do.”

Article